This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
Introduction It’s time to discuss Steel Dynamics (NASDAQ:STLD). This Indiana-based steel giant is one of America’s best-performing industrial stocks and one of the few...
Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify This is an abridged conversation from Seeking Alpha’s Investing Experts...
Co-authored with “Hidden Opportunities.” The U.S. economy continues to slow down as the Federal Reserve continues its inflation containment efforts. While rates have been...
As fears about Beijing’s potential invasion of Taiwan once again gain traction and prompt investors like Warren Buffett to unwind their long positions in...
Kinnate Biopharma (NASDAQ:KNTE) develops small molecule kinase inhibitors to treat genomically defined cancers. The company has two molecules in the clinic, exarafenib and KIN-3248....